Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyocholic acid species as novel biomarkers for metabolic disorders
Xiaojiao Zheng, Tianlu Chen, Aihua Zhao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Bile acid metabolism and signaling, the microbiota, and metabolic disease
Jingwei Cai, Bipin Rimal, Changtao Jiang, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108238-108238
Open Access | Times Cited: 203
Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes
Jing Zhang, Yueqiong Ni, Lingling Qian, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 112
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 111
Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
Baoyi Guan, Jinlin Tong, Haiping Hao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2129-2149
Open Access | Times Cited: 109
The intestinal clock drives the microbiome to maintain gastrointestinal homeostasis
Marjolein Heddes, Baraa Altaha, Yunhui Niu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
Jing Zhong, Xiaofang He, Xinxin Gao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 48
Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity
Mingliang Zhao, Zhenxing Ren, Aihua Zhao, et al.
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 1000-1012.e6
Open Access | Times Cited: 27
Diabetes in China: epidemiology, pathophysiology and multi-omics
Weiping Jia, Juliana C.N. Chan, Tien Yin Wong, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice
Noëmie Daniel, Renato Tadeu Nachbar, Thi Thu Trang Tran, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Metabolomics meets systems immunology
Jianbo Fu, Feng Zhu, Cheng‐Jian Xu, et al.
EMBO Reports (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 26
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Physiological Role of Bile Acids Modified by the Gut Microbiome
Yoshimitsu Kiriyama, Hiromi Nochi
Microorganisms (2021) Vol. 10, Iss. 1, pp. 68-68
Open Access | Times Cited: 52
Bile Acid Detection Techniques and Bile Acid-Related Diseases
Xiang Zhao, Zitian Liu, Fuyun Sun, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 31
Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes
Santosh Lamichhane, Partho Sen, Alex M. Dickens, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100762-100762
Open Access | Times Cited: 31
The Potential of Bile Acids as Biomarkers for Metabolic Disorders
Chang Yin, Ruqing Zhong, Weidong Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12123-12123
Open Access | Times Cited: 17
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 6
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Mariana X. Byndloss, Suzanne Devkota, Frank A. Duca, et al.
Diabetes Care (2024)
Open Access | Times Cited: 6
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review
Yu Pi, Miaoyu Fang, Yanpin Li, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2838-2838
Open Access | Times Cited: 6
Lactiplantibacillus plantarum ATCC8014 Alleviates Postmenopausal Hypercholesterolemia in Mice by Remodeling Intestinal Microbiota to Increase Secondary Bile Acid Excretion
Shurui Zhang, Ronghui Liu, Yuxin Ma, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 12, pp. 6236-6249
Closed Access | Times Cited: 5
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation
Jiyan Su, Xiaojie Lin, Dan Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Mariana X. Byndloss, Suzanne Devkota, Frank A. Duca, et al.
Diabetologia (2024) Vol. 67, Iss. 9, pp. 1760-1782
Open Access | Times Cited: 5
New drug therapies for metabolic dysfunction-associated steatohepatitis
John Y.L. Chiang
Liver Research (2025)
Open Access
A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial
Xiaorong Wu, Alvin Surya Tjahyo, Vera Sergeyevna Brok Volchanskaya, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tris (2-chloroethyl) phosphate (TCEP) induces obesity and hepatic steatosis via FXR-mediated lipid accumulation in mice: Long-term exposure as a potential risk for metabolic diseases
Daqian Yang, Xiangjuan Wei, Ziyi Zhang, et al.
Chemico-Biological Interactions (2022) Vol. 363, pp. 110027-110027
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top